Core Viewpoint - Centene Corporation is facing potential legal claims regarding violations of federal securities laws and unlawful business practices following a significant drop in stock price after withdrawing its 2025 earnings guidance [1][2]. Group 1: Company Performance - On July 2, 2025, Centene's stock price fell over 39.5% during intraday trading after the company announced the withdrawal of its 2025 earnings guidance due to higher-than-expected costs related to Medicaid enrollees and underperformance in its Affordable Care Act plans [2]. - The company indicated that its Medicaid business has seen an increase in medical cost trends in areas such as behavioral health, home health, and high-cost drugs [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Centene on behalf of its stockholders, focusing on whether the company has violated federal securities laws [1]. - The law firm is reaching out to long-term stockholders who may have suffered losses or have information regarding these claims [3].

Core Viewpoint - Lowey Dannenberg P.C. is investigating KBR, Inc. for potential violations of federal securities laws, indicating possible legal issues for the company [1]. Group 1: Investigation Details - The investigation targets KBR, Inc. due to potential violations of federal securities laws, which may affect the company's reputation and financial standing [1]. - Investors who have suffered losses exceeding $100,000 in KBR securities are encouraged to participate in the investigation [2]. Group 2: About Lowey Dannenberg - Lowey Dannenberg is a law firm specializing in representing institutional and individual investors who have experienced financial losses due to corporate fraud and violations of federal laws [3]. - The firm has a strong track record in prosecuting multi-million-dollar lawsuits and has successfully recovered billions for investors [3].

NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. (“Humana”) (NYSE: HUM), resulting from allegations of providing potentially misleading business information to the investing public. If you have non-public information that could assist in the Humana investigation, or if you are a Humana investor who suffered a loss and would like to learn more, you can provide your information HERE. You can also con ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Tempus AI, Inc. regarding possible violations of federal securities laws and other unlawful business practices [1][2] Group 1: Investigation and Claims - The investigation by Bragar Eagel & Squire, P.C. is on behalf of Tempus stockholders [1] - Spruce Point Capital Management published a report raising concerns about Tempus, including aggressive accounting practices and the background of several board members with troubled companies [2] - Following the report, Tempus's stock price experienced a significant decline during intraday trading on May 28, 2025 [2] Group 2: Company Background - Tempus AI, Inc. is publicly traded on NASDAQ under the ticker symbol TEM [2] - Bragar Eagel & Squire, P.C. is a law firm that represents individual and institutional investors in various types of litigation [4]

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ:SATS) on behalf of EchoStar stockholders. Our investigation concerns whether EchoStar has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On May 12, 2025, The Wall Street Journal reported that the Federa ...